News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,758 Results
Type
Article (9249)
Company Profile (55)
Press Release (223454)
Section
Business (75141)
Career Advice (321)
Deals (13810)
Drug Delivery (84)
Drug Development (23343)
Employer Resources (24)
FDA (7545)
Job Trends (6412)
News (124240)
Policy (13639)
Tag
Academia (467)
Accelerated approval (2)
Adcomms (4)
Allergies (27)
Alliances (19638)
ALS (23)
Alzheimer's disease (221)
Antibody-drug conjugate (ADC) (45)
Approvals (7591)
Artificial intelligence (49)
Autoimmune disease (7)
Automation (7)
Bankruptcy (96)
Best Places to Work (4708)
BIOSECURE Act (17)
Biosimilars (53)
Biotechnology (38)
Bladder cancer (30)
Brain cancer (8)
Breast cancer (62)
Cancer (733)
Cardiovascular disease (54)
Career advice (269)
Career pathing (6)
CAR-T (94)
Cell therapy (255)
Cervical cancer (5)
Clinical research (19133)
Collaboration (353)
Company closure (1)
Compensation (78)
Complete response letters (19)
COVID-19 (1213)
CRISPR (15)
C-suite (87)
Cystic fibrosis (18)
Data (806)
Denatured (2)
Depression (9)
Diabetes (131)
Diagnostics (1771)
Digital health (3)
Diversity, equity & inclusion (3)
Drug discovery (33)
Drug pricing (63)
Drug shortages (26)
Duchenne muscular dystrophy (22)
Earnings (34304)
Editorial (24)
Employer branding (2)
Employer resources (21)
Events (29815)
Executive appointments (249)
FDA (8131)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (210)
Gene editing (47)
Generative AI (3)
Gene therapy (145)
GLP-1 (296)
Government (1754)
Grass and pollen (3)
Guidances (84)
Healthcare (5239)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (19)
Indications (16)
Infectious disease (1273)
Inflammatory bowel disease (33)
Inflation Reduction Act (4)
Influenza (28)
Intellectual property (37)
Interviews (52)
IPO (5650)
IRA (31)
Job creations (1907)
Job search strategy (258)
Kidney cancer (7)
Labor market (22)
Layoffs (179)
Leadership (2)
Legal (2940)
Liver cancer (18)
Lung cancer (113)
Lymphoma (74)
Machine learning (3)
Management (7)
Manufacturing (357)
MASH (10)
Medical device (6041)
Medtech (6044)
Mergers & acquisitions (8398)
Metabolic disorders (283)
Multiple sclerosis (23)
NASH (1)
Neurodegenerative disease (26)
Neuroscience (356)
NextGen: Class of 2025 (1786)
Non-profit (677)
Now hiring (15)
Obesity (152)
Opinion (67)
Ovarian cancer (21)
Pain (24)
Pancreatic cancer (27)
Parkinson's disease (35)
Partnered (12)
Patents (78)
Patient recruitment (34)
Peanut (13)
People (17503)
Pharmaceutical (14)
Pharmacy benefit managers (14)
Phase I (5799)
Phase II (7785)
Phase III (7343)
Pipeline (688)
Policy (86)
Postmarket research (784)
Preclinical (2158)
Press Release (43)
Prostate cancer (44)
Psychedelics (3)
Radiopharmaceuticals (155)
Rare diseases (94)
Real estate (3376)
Recruiting (13)
Regulatory (9858)
Reports (19)
Research institute (460)
Resumes & cover letters (27)
Rett syndrome (4)
RNA editing (2)
RSV (14)
Schizophrenia (11)
Series A (32)
Series B (13)
Service/supplier (5)
Sickle cell disease (15)
Special edition (8)
Spinal muscular atrophy (39)
Sponsored (12)
Startups (908)
Stomach cancer (5)
Supply chain (60)
Tariffs (42)
The Weekly (16)
Vaccines (320)
Venture capitalists (12)
Weight loss (119)
Women's health (8)
Date
Today (97)
Last 7 days (354)
Last 30 days (1088)
Last 365 days (11537)
2025 (4032)
2024 (12545)
2023 (14391)
2022 (19298)
2021 (20772)
2020 (19806)
2019 (14844)
2018 (11181)
2017 (11460)
2016 (10558)
2015 (12511)
2014 (9459)
2013 (7939)
2012 (8968)
2011 (9677)
2010 (8224)
Location
Africa (235)
Alabama (41)
Alaska (3)
Arizona (66)
Arkansas (5)
Asia (18177)
Australia (2096)
California (2155)
Canada (610)
China (277)
Colorado (95)
Connecticut (94)
Delaware (54)
Europe (29464)
Florida (313)
Georgia (82)
Idaho (22)
Illinois (174)
India (22)
Indiana (108)
Iowa (4)
Japan (85)
Kansas (28)
Kentucky (9)
Louisiana (3)
Maine (37)
Maryland (376)
Massachusetts (1451)
Michigan (119)
Minnesota (150)
Mississippi (2)
Missouri (22)
Montana (8)
Nebraska (11)
Nevada (17)
New Hampshire (50)
New Jersey (693)
New Mexico (7)
New York (617)
North Carolina (403)
North Dakota (9)
Northern California (936)
Ohio (106)
Oklahoma (8)
Oregon (10)
Pennsylvania (456)
Puerto Rico (3)
Rhode Island (7)
South America (395)
South Carolina (3)
Southern California (895)
Tennessee (22)
Texas (299)
United States (8221)
Utah (72)
Virginia (44)
Washington D.C. (30)
Washington State (169)
West Virginia (1)
Wisconsin (22)
232,758 Results for "grand river aseptic manufacturing".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
March 25, 2025
·
3 min read
Press Releases
Charles River Laboratories Announces First-Quarter 2025 Results
May 7, 2025
·
19 min read
Press Releases
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
April 30, 2025
·
6 min read
Business
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Charles River Laboratories International, Inc. today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement.
June 25, 2024
·
4 min read
Business
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a highly respected, global provider of drug discovery, development, and manufacturing solutions, today announced the signing of a letter of intent allowing for the transfer, testing and validation of FibroBiologics’ technology.
April 25, 2024
·
4 min read
Press Releases
FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic
February 27, 2025
·
5 min read
Press Releases
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
April 22, 2025
·
6 min read
Press Releases
Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
May 7, 2025
·
10 min read
Press Releases
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
April 24, 2025
·
3 min read
Press Releases
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
April 15, 2025
·
1 min read
1 of 23,276
Next
